Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven I. Sherman

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|November 28, 2009
Tyrosine kinase inhibitors and the thyroidSteven I Sherman
Thyroid : Official Journal of the American Thyroid Association|December 17, 2009
Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advancesMartin Schlumberger, Steven I Sherman
Endocrinology and Metabolism Clinics of North America|February 6, 2019
Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid CancerSteven P Weitzman, Steven I Sherman
Endocrine-Related Cancer|January 14, 2012
Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinomaMaria E Cabanillas, Steven I Sherman
Endocrine Reviews|April 12, 2013
Evolving approaches to patients with advanced differentiated thyroid cancerBryan R Haugen, Steven I Sherman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2022
Redifferentiation Therapy-Returning to Our Roots in a Post-Kinase Inhibitor WorldMaria E Cabanillas, Naifa L Busaidy, Steven I Sherman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 25, 2014
Unique characteristics and outcomes of patients diagnosed with both primary thyroid and primary renal cell carcinomaAubrey A Carhill, Danielle R Litofsky, Steven I Sherman
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
The safety of incretin-based therapies--review of the scientific evidenceDaniel J Drucker, Steven I Sherman, Richard M Bergenstal, et al.
Annals of Diagnostic Pathology|July 22, 2021
Non-functional water clear cell parathyroid carcinoma masquerading as medullary thyroid carcinomaMohamed Khalil, Mark Zafereo, Maria Gule-Monroe, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
The <i>De Novo</i> Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer RecurrenceNgwe Yin, Steven I Sherman, Youngju Pak, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Best Practice & Research. Clinical Endocrinology & Metabolism|November 28, 2009
Tyrosine kinase inhibitors and the thyroidSteven I Sherman
Thyroid : Official Journal of the American Thyroid Association|December 17, 2009
Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advancesMartin Schlumberger, Steven I Sherman
Endocrinology and Metabolism Clinics of North America|February 6, 2019
Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid CancerSteven P Weitzman, Steven I Sherman
Endocrine-Related Cancer|January 14, 2012
Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinomaMaria E Cabanillas, Steven I Sherman
Endocrine Reviews|April 12, 2013
Evolving approaches to patients with advanced differentiated thyroid cancerBryan R Haugen, Steven I Sherman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2022
Redifferentiation Therapy-Returning to Our Roots in a Post-Kinase Inhibitor WorldMaria E Cabanillas, Naifa L Busaidy, Steven I Sherman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 25, 2014
Unique characteristics and outcomes of patients diagnosed with both primary thyroid and primary renal cell carcinomaAubrey A Carhill, Danielle R Litofsky, Steven I Sherman
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
The safety of incretin-based therapies--review of the scientific evidenceDaniel J Drucker, Steven I Sherman, Richard M Bergenstal, et al.
Annals of Diagnostic Pathology|July 22, 2021
Non-functional water clear cell parathyroid carcinoma masquerading as medullary thyroid carcinomaMohamed Khalil, Mark Zafereo, Maria Gule-Monroe, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
The <i>De Novo</i> Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer RecurrenceNgwe Yin, Steven I Sherman, Youngju Pak, et al.
Pageof 15